Benzinga's Top Downgrades

Analysts at Cantor Fitzgerald downgraded Endo Health Solutions

from “hold” to “sell.” The target price for Endo Health Solutions is set to $30. Endo Health's shares closed at $35.96 yesterday. Analysts at Morgan Stanley downgraded First Horizon National

from “overweight” to “neutral.” The target price for First Horizon National is set to $11. First Horizon National's shares closed at $11.25 yesterday. Analysts at Piper Jaffray downgraded Vera Bradley

from “overweight” to “neutral.” The price target for Vera Bradley has been lowered from $32 to $24. Vera Bradley's shares closed at $22.46 yesterday. Berenberg downgraded Oracle

from “buy” to “sell.” The target price for Oracle has been lowered from $35 to $28. Oracle's shares closed at $34.12 yesterday.